A strategy to detect beta-thalassaemia minor.

Area of Science:

• Hematology
• Medical Diagnostics
• Genetics

Background:

• Haemoglobinopathies, including beta-thalassaemia minor, are significant public health concerns.
• Accurate detection of beta-thalassaemia minor is crucial for genetic counseling and management.
• Existing methods for detecting beta-thalassaemia minor using red-blood-cell indices have limitations.

Purpose of the Study:

• To compare existing red-blood-cell indices methods for detecting beta-thalassaemia minor.
• To develop and validate a novel, more accurate method for identifying beta-thalassaemia minor heterozygotes.

Main Methods:

• A comprehensive study involving 3734 adults tested for haemoglobin A2, with 1973 showing microcytosis.
• Comparison of established red-blood-cell indices for beta-thalassaemia minor detection.
• Development of a new three-part diagnostic method: hemoglobin electrophoresis, MCV² x MCH calculation, and targeted HbA2 determination.

Main Results:

• No single existing method could identify all beta-thalassaemia minor heterozygotes.
• The newly devised method demonstrated high efficacy, detecting 137 out of 138 heterozygotes.
• The new method exhibited a low false-positive rate of 4.4%.

Conclusions:

• The novel diagnostic approach integrating electrophoresis, red-blood-cell indices, and HbA2 measurement significantly improves beta-thalassaemia minor detection.
• This method offers a more reliable tool for identifying individuals with beta-thalassaemia minor compared to existing techniques.
• The findings support the clinical utility of this combined method in screening and diagnostic settings.